Vor Biopharma (VOR) Non-cash Items (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Non-cash Items data on file, last reported at $109.8 million in Q1 2026.

• Quarterly Non-cash Items rose 846.55% year-over-year to $109.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $109.8 million (up 846.55% YoY) and the FY2025 annual result came in at $181128.0, down 14.16% from the prior year.
• Non-cash Items improved to $109.8 million in Q1 2026 per VOR's latest filing, from $181128.0 in the prior quarter.
• Across five years, Non-cash Items topped out at $109.8 million in Q1 2026 and bottomed at $181128.0 in Q4 2025.
• The 5-year median for Non-cash Items is $16.8 million (2022), against an average of $25.4 million.
• The widest annual swing landed in 2022, when Non-cash Items surged 2011.41%; it then slumped 93.32% in 2023.
• Tracing VOR's Non-cash Items over 5 years: stood at $14.9 million in 2022, then tumbled by 93.32% to $999000.0 in 2023, then plunged by 78.88% to $211000.0 in 2024, then decreased by 14.16% to $181128.0 in 2025, then surged by 60520.11% to $109.8 million in 2026.
• Per Business Quant, the three latest VOR Non-cash Items figures stand at $109.8 million (Q1 2026), $181128.0 (Q4 2025), and $82.3 million (Q3 2025).

Peer Comparison